Skip to main content
Equibles
PYXS logo

PYXS · Pyxis Oncology, Inc. · Investor Relations

Track PYXS — free

Use PYXS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PYXS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.68 -0.03 (-1.75%) At close · Oct 23
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$140.13M
Shares
83.41M
Volume · Oct 23 626.79K Avg daily vol (3M) 1.23M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Key facts CIK 1782223 CUSIP 747324101 13F (30d) 9 filings 9 filers Visit website Investor relations